Long-term Outcomes After Resection of Primary Duodenal Adenocarcinoma

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05134961

Enrollment

113

Registered

2021-11-26

Start date

1999-01-01

Completion date

2021-09-30

Last updated

2021-11-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Duodenal Cancer

Brief summary

The aim of this study is to examine the long-term outcomes after curatively intended resection of duodenal adenocarcinoma.

Interventions

PROCEDUREPancreaduodenectomy and possible adjuvant therapy

Adjuvant therapy was generally offered to patients with T4 or lymph node positive disease. As no national Danish guidelines exist, patients were treated based on the oncologists' preference.

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Inclusion criteria

* Patients subjected to resection of primary duodenal adenocarcinoma

Exclusion criteria

* None.

Design outcomes

Primary

Measure	Time frame	Description
3-year survival	Three years	Cumulative survival after three years

Secondary

Measure	Time frame	Description
Duodenal cancer recurrence	5 years	Recurrence found by computed tomography scan

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026